HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 47, Issue 1, 2001, Pages 33-42

  Piroth, Lionel ^a   Desbiolles, Norbert ^a   Mateo Ponce, Vanessa ^a   Martin, Laurent ^b   Lequeu, Catherine ^a   Charles, Pierre Emmanuel ^a   Portier, Henri ^a   Chavanet, Pascal ^a  

^a HÔPITAL DU BOCAGE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ERYTHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE; ERYTHROMYCIN LACTOBIONATE; PENICILLIN G; TELITHROMYCIN;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLEARANCE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFICACY; LUNG; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RABBIT; SPLEEN; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

EID: 0035187733     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/47.1.33     Document Type: Article

References (34)

1. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain
2. Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases
3. Community-acquired pneumonia in adults: Guidelines for management. Infectious disease society of America
4. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: A population-based study
5. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta
6. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenza, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season
7. Pneumococcal resistance patterns in Europe
8. Pneumococcal resistance in the UK
9. Sensitivity to sparfloxacin and other antibiotics of Streptococcus pneumoniae, Haemophilus influenza and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory multicentre study. SPAR study group. Surveillance programme of antibiotic resistance
10. The Nearchus project: Antibiotic susceptibility of respiratory pathogens and clinical outcome in lower respiratory tract infections at 27 centres in the UK
11. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program
12. Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State
13. Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in Australia
14. Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan
15. The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent
16. Development of a new model of penicillin-resistant Streptococcus pneumoniae and amoxicillin treatment by reproducing human pharmacokinetics
17. Susceptibility testing of antimicrobials in liquid media
18. Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits
19. Measurement of antibiotics in human body fluids: Techniques and significance
20. Pharmacokinetics of parenterally administered amoxycillin
21. Penetration into lung tissue after intravenous administration of amoxycillin/clavulanate
22. Pharmacokinetics of intravenous erythromycin
23. General principles of pharmacokinetics
24. Pharmacokinetic analysis using an electrical analogue
25. Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against Gram-positive cocci of known erythromycin susceptibility status
26. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents
27. Antipneumococcal activities of a ketolide (HMR3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin)
28. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany
29. Synthesis and antibacterial activity of ketolides (6-Ο-methyl-3-oxoerythromycin derivatives): A new class of antibacterials highly potent against macrolide-resistant and -susceptible pathogens
30. A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin
31. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against Gram-positive bacteria
32. Immunomodulating effects of antibiotics: Literature review
33. Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice